Teknor Apex has bought the assets of bankrupt Danimer Scientific for about $19 million. The Danimer Scientific acquisition moves the company’s polyhydroxyalkanoate (PHA) technology, including the Nodax brand, to one of the largest privately held plastics compounders in the world. It ends a bad chapter for Danimer and may start a better one for commercial PHA.
How Danimer got here
Danimer Scientific was the most visible name in PHA bioplastics. From Bainbridge, Georgia, it developed a family of PHA resins sold as Nodax and pitched as fully biodegradable replacements for conventional plastic in food packaging, drinking straws and coatings. A 2020 SPAC merger took it public at a peak market capitalization above $8 billion.
What followed was worse than a downturn. Danimer faced allegations that it had overstated how biodegradable its products were, which brought an SEC investigation and securities fraud lawsuits. Production scale-up ran slower and cost more than projected. By late 2024 the losses and debt sent the company into Chapter 11.
Several buyers circled the bankruptcy. Teknor Apex won at $19 million, against the billions the company was once valued at. Our Bio-based Polymers overview covers the PHA family itself.
What the deal includes
Danimer’s PHA intellectual property, its manufacturing equipment and facilities, the Nodax brand and its customer and supplier relationships. Teknor Apex says it plans to fold PHA into its wider product portfolio.
Teknor Apex runs over 30 manufacturing sites across North America, Europe and Asia from its base in Pawtucket, Rhode Island, on estimated annual revenues above $1.5 billion. Danimer was a single-product startup living on external funding. That difference is the substance of the story.
What it changes for PHA
A compounder brings something Danimer never had: the infrastructure, the customers and the technical depth to blend PHA with other polymers into formulations built for particular applications.
That matters commercially. Pure PHA resin is expensive against conventional plastic and always will be at current volumes. PHA-based compounds can trade some biodegradability for cost and performance, and compounding is how most specialty polymers reached mainstream use in the first place.
Kaneka, Newlight Technologies and CJ Bio will be watching. The Market & Trends picture points to growing demand; whether PHA can supply it at scale is still unproven.
What happens next
Teknor Apex has not said how it will integrate the technology. The open questions are whether it restarts production at Danimer’s existing plants, builds new capacity, or begins by compounding PHA with other materials and buying resin elsewhere.
The cautious route would start with high-value applications, compostable food packaging, agricultural film and marine-degradable products, before going anywhere near commodity volumes. Given how Danimer failed, caution seems likely.
For how PHA fits into end-of-life pathways, see our Knowledge Zone.
